Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Can Philip Morris' Low Risk Products Counter Industry Woes?

Published 11/23/2017, 10:17 PM
Updated 07/09/2023, 06:31 AM

Philip Morris International Inc (NYSE:PM) has been struggling with lower cigarette volumes, due to reduced consumption rates. To worsen matters, the court recently issued an order which guides cigarette companies to endorse anti-smoking campaigns. Nevertheless, Philip Morris has been diverting its attention toward Reduced Risk Products (RRPs) to stay afloat in the tobacco industry.

Thanks to the challenges stemming from lower cigarette volumes, Philip Morris’ top- and bottom-lines missed the Zacks Consensus Estimates in the third quarter of 2017. Notably, this marked the company’s third consecutive period of earnings and sales miss.

Consequently, the company’s shares have dipped approximately 8% since it posted third-quarter results on Oct 19. Philip Morris’s shares have lost 9.8% in the past three months compared with the industry’s decline of 0.6%.

Let’s delve into the factors which have been impacting Philip Morris’s performance lately and the efforts undertaken to uplift the company’s performance.

Anti-Smoking Advertisements Reduce Smoking Rates

Despite a formidable decline in cigarette consumption in the past decade, smoking is still considered as one of the leading causes of death in the United States. Further, federal authorities claim that tobacco companies have not informed consumers about the dangers and addictive nature associated with smoking. As per the new court order, companies will be forced to acknowledge the perils of smoking through corrective advertisements circulated through television channels, newspapers, websites, store displays and cigarette packs. Further, the court directed Altria Group (NYSE:MO) and R.J. Reynolds Tobacco Co. to bear the expenses of the campaign.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Stringent regulations imposed by government authorities surrounding tobacco consumption have always posed challenges for major players such as British American Tobacco (NYSE:BTI) , Altria and Vector Group (NYSE:VGR) . Cigarette consumption rates have declined globally due to precautionary labels and higher tax rates. The recent order to roll out anti-smoking advertisements is a major step to restrict tobacco consumption. This is expected to lower revenue prospects for almost all the companies operating in the industry.

Industry Hurdles Hurt Q3 Results & View: Estimates Decline

During third-quarter 2017, Philip Morris’s net revenues were hurt by a 3.6% decline in combustible products. Total shipment volumes in this category also declined 4.1%. The downside stemmed from lower volumes in the EU, EEMA regions and in Latin America & Canada. As a result, total cigarette and heated tobacco unit shipment volume declined by 0.5% in the quarter.

Management lowered earnings guidance for 2017, due to the headwinds surrounding the industry. Earnings are now expected in the range of $4.75-$4.80, lower than the previous range of $4.78 to $4.93. Consequently, the Zacks Consensus Estimate for 2017 revised two cents downward in the past 30 days to $4.75.

Reduced Risk Products Expected to Uplift Performance

Nonetheless, Philip Morris’s RRPs performance has been impressive lately. Consumers have been showing increased preference for such products, which have a lower negative impact on health. During the third quarter, the company generated revenues of $947 million from RRPs, significantly higher than $212 million reported in the prior-year quarter. This has driven the company’s overall top-line results. Additionally, heated tobacco unit shipment volume of 9.7 billion units, reflected a radical improvement from 2.1 billion units recorded in third-quarter 2016.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Considering such upsides associated with RRPs, Philip Morris has been making aggressive investments to expand heated tobacco units or IQOS devices along with e-vapor products. Additionally, the marketing and technology sharing agreement between Philip Morris and Altria Group, which is currently under FDA’s review, is expected to boost the companies’ business in the forthcoming periods.

Philip Morris has been striving to adapt with the changing industry conditions to meet consumer needs as evident from the smokeless cigarette category’s performance. We hope that such efforts will help this Zacks Rank #3 (Hold) company to stay afloat amid tough industry conditions. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>



Altria Group (MO): Free Stock Analysis Report

Philip Morris International Inc (PM): Free Stock Analysis Report

British American Tobacco p.l.c. (BTI): Free Stock Analysis Report

Vector Group Ltd. (VGR): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.